{"schema_version":"1.0","hypothesis_id":23411,"triple":{"drug":"pentamidine","drug_canonical":"pentamidine","mediator":"S100B","mediator_canonical":"s100b","outcome":"ALS","outcome_canonical":"amyotrophic lateral sclerosis"},"domain":{"domain":"cross_domain","source":"multiple_sclerosis","target":"als"},"provenance_completeness":"partial_backfill","completeness_notes":"Backfilled retroactively from DB state on 2026-05-13. The pipeline_run this row references was created by the backfill script, not by the actual generation orchestrator. Source papers, claims, scoring, and embedding config are recovered; generation-time metadata (exact git commit at gen time, host, exact command) is not recoverable.","source_papers":[{"doi":"10.3390/ijms26135948","pmid":"40649727","year":2025,"roles":["drug_mediator"],"title":"Effect on Different Glial Cell Types of S100B Modulation in Multiple Sclerosis Experimental Models","journal":"Int J Mol Sci","work_id":213322,"publication_date":"2025-06-20"},{"doi":"10.1093/braincomms/fcac076","pmid":"35620168","year":2022,"roles":["drug_mediator"],"title":"S100B inhibition protects from chronic experimental autoimmune encephalomyelitis","journal":"Brain Commun","work_id":206464,"publication_date":"2022-03-24"},{"doi":"10.3390/ijms23042184","pmid":"35216298","year":2022,"roles":["mediator_outcome"],"title":"The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice","journal":"Int J Mol Sci","work_id":53970,"publication_date":"2022-02-16"},{"doi":"10.3390/cells9030748","pmid":"32197530","year":2020,"roles":["drug_mediator"],"title":"The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing—Remitting Multiple Sclerosis Mouse Model","journal":"Cells","work_id":199396,"publication_date":"2020-03-18"},{"doi":"10.1155/2017/1626204","pmid":"28713206","year":2017,"roles":["mediator_outcome"],"title":"The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1<sup>G93A</sup> Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes","journal":"Mediators Inflamm","work_id":51754,"publication_date":"2017-01-01"},{"doi":"10.3389/fncel.2015.00485","pmid":"26733811","year":2015,"roles":["mediator_outcome"],"title":"Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis","journal":"Front Cell Neurosci","work_id":51355,"publication_date":"2015-12-22"}],"source_paper_count":6,"extracted_claims":[{"side":"drug_mediator","object":"S100B","context":"in vitro and in vivo in relapsing-remitting EAE mouse model","subject":"Pentamidine","work_id":199396,"claim_id":146526,"polarity":"positive","predicate":"inhibits","confidence":0.95,"extraction_run_id":25},{"side":"drug_mediator","object":"S100B","context":"in chronic experimental autoimmune encephalomyelitis","subject":"pentamidine","work_id":206464,"claim_id":156523,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":25},{"side":"drug_mediator","object":"S100B","context":"in experimental autoimmune encephalomyelitis models","subject":"pentamidine","work_id":213322,"claim_id":163500,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":25},{"side":"mediator_outcome","object":"ALS","context":"in spinal cords of ALS patients","subject":"S100B","work_id":51355,"claim_id":30401,"polarity":"positive","predicate":"correlates_with","confidence":0.9,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in SOD1G93A models","subject":"S100B","work_id":51754,"claim_id":31328,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"at onset in SOD1 G93A mouse lumbar spinal cord","subject":"S100b","work_id":53970,"claim_id":35297,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":15}],"extracted_claim_count":6,"extraction":{"model":"deepseek-v4-flash","model_source":"configured","prompt_version":"v1_2026_05_07","run_ids":[15,25]},"bridge":{"a_to_b_predicate":"inhibits","b_to_c_predicate":"correlates_with","a_to_b_evidence_count":3,"b_to_c_evidence_count":3,"edge_support_log_ab":1.3862943611198906,"edge_support_log_bc":1.3862943611198906,"novelty_factor":1.0,"direct_a_to_c_count":0},"embedding":{"model":"bge-m3","dim":1024,"max_length":8192,"similarity_scores":{}},"scoring":{"method":"swanson_abc_log_evidence_with_novelty_penalty","formula":"score = min((log(ab+1) + log(bc+1)) * novelty / 10, 1.0); novelty = 1.0 if direct==0 else 0.7 / (direct+1)","score_raw":0.2772588722239781,"score":0.2772588722239781,"quality_tier":"high","quality_reason":null},"pipeline_run":{"id":4,"run_uuid":"eb8b7730-d92e-4cd5-95dd-95f6c5d62cc2","command":"scripts/backfill_provenance_v2.py:v2_2026_05_12","status":"completed","git_commit":"9996ffaa56e9b7cd5f677bd8203624c2c18aa000","host":"MacBook-Pro-Daniel96.local","started_at":"2026-05-12T21:35:53.363326+00:00","ended_at":"2026-05-12T21:43:41.903387+00:00","notes":"Retroactive provenance backfill on 2026-05-13 for snapshot v2_2026_05_12. Synthetic pipeline_runs row — original generation run records are lost (pre-date provenance schema). All recoverable fields populated from current DB state (claims, works, repurposing_hypotheses); pipeline_run record is synthetic, hence completeness='partial_backfill'.\nBackfilled 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.","domains":["als","alzheimer","depression","epilepsy","glioblastoma","inflammatory_bowel_disease","multiple_sclerosis","pancreatic_cancer","rheumatoid_arthritis","type_2_diabetes"]},"generated_at":"2026-05-12T21:43:40.211207+00:00"}